STAT: Early Price Setting, Other Market Access Planning is Key for Early-Stage Drug, Device Companies Back Bay in the News, Life Science MediaChristopher Leo, PhD October 29, 2019Drug Pricing, Market Access, Emerging BioPharma, Emerging Companies
The Disappearance of Chinese Capital in US Biotechnology BlogBack Bay Life Science AdvisorsSeptember 5, 2019Biotech Financing
Changing the Game: Digital Solutions in Healthcare BlogBack Bay Life Science AdvisorsJune 19, 2019Digital Healthcare
